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Objectives: To investigate how body composition components ﬁt body mass index (BMI) categories and
whether they could be considered as markers of metabolic and cardiovascular health.
Design: Prospective study.
Setting: A center for preventive medicine.
Participants: Six hundred and sixteen consecutive outpatients: mean age of 56.0±10.0 years; 74.6% aged
≥50 years and 61.4% were females.
Measurements: Fat mass (FM) and muscle mass (MM) were obtained by dual energy X-ray absorp-
tiometry analyses. Metabolically unhealthy individuals were deﬁned as people with biological features
of dyslipidemia, hyperuricemia, diabetes, and/or hepatitis steatosis. Documented hypertension and/or
atherosclerosis of one major artery, at least, deﬁned individuals with cardiovascular complications.
Results: According to BMI categories, 45.8% of the sample was of normal weight, while 19.2% and 16.5%
were classiﬁed as overweight and obese. A total of 78.0% and 86.3% of overweight and obese individuals
were metabolically unhealthy respectively, 46.8% and 52.6% of subjects classiﬁed into normal and under-
weight BMI categories were also diagnosed. Cardiovascular complications mainly concerned the two
highest BMI groups (78.2%). Inmultifactorial analyses the overweight and obese BMI categorieswere pre-
dictive of health outcomes [respectively, odds ratio (OR) =8.05, 95% conﬁdence interval (CI): 4.23–12.07
and 5.74, 95% CI: 3.41–8.98]. FM andMM indexeswere signiﬁcantly associatedwithmetabolic (OR=1.30,
95% CI: 1.19–1.47; and 0.84, 95% CI: 0.78–0.91) and cardiovascular (OR=1.22, 95% CI: 1.13–1.32; and 0.72,
95% CI: 0.65–0.80) health respectively, and FM/MM (respectively, OR=15.45, 95% CI: 11.77–20.17; and
16.61, 95% CI: 10.49–21.33) as well.
Conclusion: Our ﬁndings suggest that FM and MM readouts are important measurements of nutritional
status and they extend the analysis of its impact on health outcomes to all BMI categories. Moreover,
they highlight the interest of measuring body composition in medical check-ups to predict metabolic
and cardiovascular diseases.
© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.∗ Corresponding author at: Nescens Centre of PreventiveMedicine, Clinic of Geno-
ier, Route du Muids, 3, CH-1272 Genolier, Switzerland. Tel.: +41 22 366 93 09;
ax: +41 22 366 93 49.
E-mail address: polang@nescens.com (P.-O. Lang).
ttp://dx.doi.org/10.1016/j.jjcc.2014.03.010
914-5087/© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reIntroduction
The question of how adult weight may inﬂuence the risk of
metabolic and cardiovascular health and inversely may promote
longevity has profound health, social, and economic implications
for individuals, communities, and the population as a whole [1]. In
almost all epidemiological studies, the degree of overweight is sim-
ply deﬁned by means of the body mass index (BMI) or Quetelet’s
served.
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ndex [2]. Expressed as the relationship between the total body
ass (in kg) and stature (in m2), it is the most widely used indica-
or of nutritional status in the general population. It was in 1997
hat a World Health Organization consultation on obesity deﬁned
re-obesity (overweight) as a BMI≥25kg/m2, and class I, II, and III
besity as BMI ≥30, 35, and 40kg/m2 respectively.
BMIhas, however, some limitations in estimatinghealth-related
isks [2,3]. Indeed, the relationships of the total body weight and
he development of major health complications are strongly linked
o the degree of adiposity. However, while it appeared obvious to
stablish normal weight as a function of height, this measurement
ccounts only for about two-thirds of the between-individual vari-
tion in total adiposity [4]. Furthermore, BMI does not account
or sex, age, and ﬁtness differences in fat mass (FM) even at the
ame body weight [5,6]. In addition, with aging, the decrease in
tature, accumulation of fatty tissues, and reduction in lean mass
i.e. bone+muscle mass) further consider BMI as a problematic
eadout of total body weight and its health-related risks [1].
Dual energy X-ray absorptiometry (DEXA) is becoming a vali-
ated, reliable, and safe technique to assess the body composition.
t uses the equivalent of less than 10% of one day’s exposure to
atural background radiation (0.001mSv) which corresponds to
ower level of radiation than a standard X-ray (0.1mSv) [7]. Thus,
he present study aims to analyze how the different DEXA-based
ody composition components [i.e. fat mass (FM) index, muscle
ass (MM) index, and FM/MM] ﬁt BMI categories and whether
hey could be considered as interesting markers of metabolic and
ardiovascular health.
aterials and methods
tudy population and design
The sample study was recruited at the Clinic of Geno-
ier (Switzerland) and consisted of 616 consecutive ambula-
ory patients consulting the Center for Preventive Medicine
www.nescens.com) for a medical check-up between January 1,
009 and December 31, 2012. Pregnant women and/or individuals
ith self-reported cardiac failure, who had a cardiac pacemaker, or
ho had previously undergone limb amputation were not consid-
red. In addition, there were not any exclusion criteria.
Brieﬂy, Nescens medical check-ups are designed in three steps.
he ﬁrst and third steps are dedicated to medical consultations,
hich are conducted before and after all the complementary inves-
igations. The medical consultation conducted before is dedicated
opersonal and familymedical histories,medications, current com-
laints and symptoms, and a complete medical examination is also
erformed. In the course of the ﬁrst consultation, patients were
nformed about the protocol prior to signing informed consent.
he results of the check-up are detailed and discussed during the
econd consultation. The second step is composed of biological,
adiological, and functional investigations. Thus, blood test anal-
ses, including in part the biological data of interest (see below
nd Table 1 for details), are carried out as well as a large panel of
adiology exams such as DEXA-scan, angio-computed tomography
CT)-scans of the supra-aortic and coronary arteries, and total body
T-scan (256-rowdetector CT-scan). In addition, a cardiologist con-
ucts a stress test on an electronically braked cycle ergometer in
ddition to aDoppler echocardiography. In order to avoid any inter-
erence due to injection of iodine-based contrast products used for
he angio- and total body CT-scans, DEXA-scans were systemat-
cally carried out ﬁrst. The data of interest were retrospectively
ollected from medical folders between April 1, 2013 and May 31,
013. The study protocol was approved by the local ethics commit-
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Data collection
Assessment of body composition
The assessment of body composition was performed with a
DEXA scan (Hologic Discovery; Hologic Inc., Bedford, MA, USA) [8].
The instrument was calibrated by using a spine phantom daily and
a step phantom weekly. All scans were performed 4–5h after the
last meal, at least, and before CT-scans. DEXA represents a three-
compartment model for estimating body composition, because it
can divide the body into three compartments: fat, bone mineral,
and all other fat-free mass that does not include bone. Thus, unlike
two-compartment models, DEXA is not subject to errors caused by
variations in bone density among different ethnicities. DEXA thus
provides bone density estimates, and regional estimates of body
composition (i.e. it can estimate the body composition of individual
parts of the body), by measuring the body’s absorbance of X-rays
at two different energies. Fat, bone mineral, and fat-free soft tis-
sue have different absorption properties. As shown in Fig. 1, DEXA
gets estimates of the body composition by scanning the entire body
in 5–10min. Data obtained were analyzed by a trained technician
with an automated software (Vertec Scientiﬁc Ltd., Reading, BERKS,
UK).
Body-composition variables chosen for the present study
included two measures of total adiposity, namely the percentage
of body fat and FM, and three measures of lean mass, namely per-
centage of body muscle, the bone mass, and MM. Subsequent to
the measurement of individuals’ height, height-adjusted indexes
were considered. Thus, height raised to the power of 2 was used
to calculate BMI [weight (kg)/height2 (m2)], FM index [FMI = FM
(kg)/height (m2)], and MM index [MMI=MM (kg)/height (m2)].
According to BMI values, for descriptive purposes, indi-
viduals were classiﬁed as underweight (<18kg/m2), normal
weight (18–24.9 kg/m2), overweight (25–29.9 kg/m2), or obese
(≥30kg/m2) [1]. For statistical analyses, 18–24.9 kg/m2 was used
as reference group because it considers normal weight individ-
uals. Body heights were measured to the nearest 0.5 cm and total
bodyweight to thenearest 0.1 kgwith calibrateddigital scales (Seca
Corp. Scale, Hamburg, Germany).
Biochemical markers
All biochemical markers considered in the study (see Table 1)
were measured at the laboratory of the Clinic of Genolier
(Synlab® Suisse – www.synlab.ch), which is accredited according
to the international standards (ISO/CEI 15189 STS 497). Fas-
ting blood samples were collected on peripheral venipuncture
before all imagery investigations. Serum levels of total choles-
terol (C), high-density lipoprotein-C, low-density lipoprotein C
(LDL-C), triglycerides, and uric acid were measured using enzy-
matic methods with Combas Integra® 400 (Hoffmann-La Roche
Ltd., Basel, Switzerland). Blood glucosewasmeasuredwith hexoki-
nasemethod; and blood glycated hemoglobin (Hb) A1c determined
by IFCC (International Federation of Clinical Chemistry and Labo-
ratory Medicine) standardized immunoturbidimetric method with
Combas Integra® 400. The serum homocysteine and lipoprotein (a)
levelsweremeasuredwith nephelometric immuno-assays on latex
particles using BN ProSpect® (Siemens AG, Munich, Germany) and
Combas Integra® 400, respectively.
Outcomes of interest
Metabolic health
Metabolically unhealthy individuals were deﬁned as par-ticipants who demonstrate biological features of dyslipidemia
(i.e. total and/or LDL hypercholesterolemia and/or hypertriglyc-
eridemia), and/or hyperuricemia and/or a diagnosis of diabetes
deﬁned as a level of HbA1c above 6.5% [9]. A diagnosis of hepatic
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Table 1
Characteristics of the individuals comprising the sample study according to BMI categories (N=616).
Characteristics Total BMI <18 18≤BMI<24.9 25≤BMI<29.9 BMI≥30 p-Value
N=616 n=114 n=282 n=118 n=102
Gender, n (%)
Female 378 (61.4) 106 (93.0) 188 (66.7) 40 (33.9) 44 (43.1) <0.00001
Age (years)
m± SD 56.0±10.0 51.8±8.9 55.4±9.4 58.0±12.2 60.1±8.1 <0.0001
Country of origin, n (%)
France 68 (11.0) 28 (24.6) 28 (9.9) 4 (3.4) 8 (7.9) <0.00001
Russia 78 (12.7) 6 (5.3) 20 (7.1) 14 (11.9) 38 (37.2)
Switzerland 400 (64.9) 78 (68.4) 212 (75.2) 74 (62.7) 36 (35.3)
Othera 70 (11.4) 2 (1.7) 22 (7.8) 26 (22.0) 20 (19.6)
Personal history, n (%)
High blood pressure 116 (18.8) 0 (0.0) 28 (9.9) 48 (40.7) 40 (39.2) <0.00001
Any cardiovascular events 2 (0.3) 0 (0.0) 0 (0.0) 2 (1.7) 0 (0.0) NS
Stroke 2 (0.3) 0 (0.0) 0 (0.0) 2 (1.7) 0 (0.0) NS
Myocardial infarcts 2 (0.3) 0 (0.0) 0 (0.0) 2 (1.7) 0 (0.0) NS
Coronaropathy 38 (6.2) 0 (0.0) 10 (3.6) 14 (11.9) 14 (13.7) 0.002
Any vascular diseaseb, n (%) 46 (7.5) 0 (0.0) 10 (3.6) 16 (13.6) 20 (19.6) <0.00001
Risk factor for cardiovascular diseases, n (%)
Family history 286 (46.4) 36 (31.6) 134 (47.5) 52 (44.1) 64 (62.8) 0.01
Tobacco consumption 200 (32.5) 12 (10.5) 70 (24.8) 54 (45.8) 64 (62.8) <0.00005
MUH, n (%) 372 (60.4) 60 (52.6) 132 (46.8) 92 (78.0) 88 (86.3) <0.00001
Hepatic steatosisc, n (%) 214 (34.7) 22 (19.3) 54 (19.1) 60 (50.8) 78 (76.5) <0.00001
Known hypercholesterolemia, n (%) 196 (31.8) 0 (0.0) 76 (26.9) 60 (50.8) 60 (58.8) <0.00001
Taking of cholesterol-lowering drugs, n (%) 66 (10.7) 0 (0.0) 18 (6.4) 24 (20.3) 24 (23.5) <0.00001
Diagnosis of diabetes, n (%) 24 (3.9) 0 (0.0) 0 (0.0) 6 (5.1) 18 (17.6) <0.00001
Total cholesterol
m± SD 5.9±1.1 5.8±0.9 5.9±1.2 5.9±1.2 5.7±1.1 NS
≥5.2mmol/L, n (%) 174 (28.3) 32 (28.1) 42 (30.0) 30 (25.4) 14 (27.4) NS
HDL cholesterol
m± SD 1.7±0.5 1.9±0.4 1.9±0.5 1.5±0.4 1.2±0.3 <0.0001
<0.9mmol/L, n (%) 16 (2.6) 0 (0.0) 4 (1.4) 6 (5.1) 6 (5.9) 0.08
Cholesterol/HDL
≥6.5, n (%) 22 (3.6) 0 (0.0) 4 (1.4) 6 (5.1) 12 (11.8) 0.003
LDL cholesterol
m± SD 3.7±1.0 3.5±0.9 3.6±1.1 3.8±0.9 3.9±0.9 NS
≥3.7mmol/L, n (%) 318 (51.8) 60 (52.6) 124 (44.3) 68 (57.6) 66 (64.7) NS
Triglycerides
m± SD 1.1±0.6 0.8±0.2 1.0±0.4 1.4±0.6 1.7±0.7 <0.0001
≥1.7mmol/L, n (%) 92 (15.0) 0 (0.0) 18 (6.4) 36 (30.5) 38 (37.2) <0.00001
HbA1cd
m± SD 5.5±0.7 5.4±0.4 5.3±0.4 5.6±0.6 6.3±1.2 <0.0001
>6.5%, n (%) 38 (6.23) 0 (0.0) 0 (0.0) 6 (5.1) 32 (31.4) <0.00001
hs-CRPe
m± SD 2.0±3.1 1.0±0.9 1.4±3.1 2.3±2.0 4.6±4.4 <0.0001
Ferritinf
m± SD 139.8±92.9 128.7±85.5 130.5±88.1 169.4±116.9 146.5±79.6 NS
Uric acidg
m± SD 281.4±94.4 211.8±40.9 253.0±74.5 321.0±94.6 381.2±78.7 <0.0001
Hyperuricemiah 64 (11.3) 0 (0.0) 10 (4.0) 20 (18.2) 34 (33.3) <0.00001
Homocysteinei
m± SD 10.5±3.1 12.3±0.7 10.2±3.4 11.2±3.2 9.9±2.5 <0.0001
Lp(a)j
m± SD 253.6±272.6 302.6±154.8 232.8±207.8 234.9±352.9 279.2±351.2 0.02
BMI, body mass index (kg/m2); m± SD, mean standard deviation; MUH, metabolically unhealthy is deﬁned by the presence of at least one metabolic disorder (hyper-
LDL, hypertriglyceridemia, and/or HbA1c>6.5%) and/or a diagnosis of hepatic steatosis; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1c, glycosylated
hemoglobin; hs-CRP, high-sensitivity C-reactive protein.
p-Values <0.05 indicates that the candidate variable is associated with the BMI categories, when it is >0.05 then “NS” is mentioned.
a From other origin means: Algeria – 4 (0.6%), Belgium – 16 (2.5%), China – 8 (1.3%), Dubai – 2 (0.4%), Egypt – 2 (0.4%), Iraq – 4 (0.6%), Kuwait – 2 (0.4%), Monaco – 6 (1.0%),
Saudi Arabia – 24 (3.8%), and Sweden – 2 (0.4%).
b Anyvasculardiseases = sufferingat least fromanycoronaropathy (symptomatic ornot), and/or a stenosis of supra aortic trunk (withorwithout symptomsor complication),
and/or an arteriopathy of the lower limbs.
c Hepatic steatosis =diagnosed by ultrasound of the abdomen and deﬁned as a liver hyperechogenicity.
d HbA1c: normal range for men=4.0–6.0% – normal range for women=4.0–6.0% – diabetes, is deﬁned when HbA1c value is above 6.5%.
e hs-CRP: normal value is <5.0mg/L.
f Ferritin: normal range for men=22–275g/L – normal range for women=10–204g/L.
g Uric acid: normal range for men=210–420mol/L – normal range for women=150–360mol/L.
s
(
t
ii Homocysteine: normal value <16mol/L.
j Lp(a) = lipoprotein (a): normal value <300mg/L.teatosis was also part of the deﬁnition. The ratio of liver-to-spleen
L/S) Hounsﬁeld units (HU) <1.0 and liver attenuation <40HU on
he abdomen 256-row detector CT-scan was used for diagnos-
ng hepatic steatosis [10]. The normal serum values for biologicalmarkers were those given by the laboratory (www.synlab.ch):
total cholesterol <5.2mmol/L; LDL cholesterol <3.7mmol/L; trigly-
cerides <1.7mmol/L; 210≤uric acid≤420 for men and 150≤uric
acid≤360 for women; and 4.0≤HbA1c≤6.0 for both genders.
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ardiovascular disease
Medical data and diagnostics of interest leading to identify
ndividuals suffering from metabolic-related cardiovascular com-
licationswerecollected throughout the twomedical consultations
rom previous reports, personal medical history, and the result
f the tests performed during the check-up. Thus, individuals
ho demonstrate documented hypertension (under treatment or
ot) and/or a signiﬁcant coronaropathy (symptomatic or not),
therosclerosis of at least one of the supra-aortic arteries (symp-
omatic or not), and/or of one large arteries of the body were
onsidered as having cardiovascular diseases [9].
tatistical analysesFor descriptive analysis, numerical variables are presented as
ean± standard deviation (m± SD) and for categorical variables
s number and percentage. Statistical tests used for the unifac-
orial comparative analysis were chosen according to the type ofa 76-year-old man with a body mass index (BMI) of 32.5 kg/m2 (height =1.79 cm;
variable, the sample size under consideration, and the number of
groups compared. Thus, numerical outcomeswere compared using
analysis of variance or Kruskal–Wallis test (when greater than two
groups), and Student’s t orMann–Whitney test (when two groups).
For categorical outcomes, 2 (Chi2) or Fisher’s exact test was used.
Linear Pearson correlation coefﬁcients (r) were calculated using a
linear regression model to measure the strengths and directions of
the linear relationships between the BMI values and the different
anthropometric and biological data.
To investigate the respective relationship between the differ-
ent anthropometric readouts of interest and the two main health
outcomes independent multifactorial logistic models have been
computed. In each model, gender and age were systematically
considered as adjustment variables, and tobacco consumption (i.e.
smoking) as a potential confounder for cardiovascular health only.
The results of these analyses are presented in the form of adjusted
ORs and 95% conﬁdence intervals (95% CI). TheHosmer–Lemeshow
test was used to assess whether the observed event rates match
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Table 2
Result of the descriptive analysis of the anthropometric data according to BMI categories (N=616).
Anthropometric data Total BMI <18 18≤BMI<24.9 25≤BMI<29.9 BMI≥30 p-Value
N=616 n=114 n=282 n=118 n=102
Height (cm) 169.7 ± 9.5 168.7 ± 7.5 168.9 ± 9.1 172.6 ± 10.7 169.5 ± 10.6 NS
Total body mass (kg) 68.6 ± 18.1 49.7 ± 4.8 61.5 ± 9.6 81.3 ± 11.3 94.4 ± 12.8 <0.0001
BMI (kg/m2) 23.7 ± 5.5 17.4 ± 0.5 21.4 ± 1.9 27.2 ± 1.5 32.9 ± 3.7 <0.0001
Bone mass (g) 2313.2 ± 493.5 2005.0 ± 270.8 2255.4 ± 425.6 2529.1 ± 537.1 2567.3 ± 576.8 <0.0001
Bone mass index (kg/m2) 0.8 ± 0.1 0.7 ± 0.07 0.8 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 <0.0001
Muscle mass (g) 47,095.3 ± 12,197.7 35,101.2 ± 3526.1 44,683.9 ± 9523.9 55,465.5 ± 10,127.9 57,484.2 ± 12,386.0 <0.0001
Muscle mass index (kg/m2) 16.2 ± 3.1 12.3 ± 0.9 15.5 ± 2.0 18.4 ± 1.8 19.8 ± 2.6 <0.0001
Muscle mass (%) 69.2 ± 8.0 70.7 ± 4.9 72.3 ± 7.1 67.9 ± 6.7 60.5 ± 7.8 <0.0001
Fat mass (g) 19,135.8 ± 9261.5 12,623.2 ± 3144.3 14,497.8 ± 4567.7 23,342.6 ± 5727.0 34,369.6 ± 7246.2 <0.0001
Fat mass index (kg/m2) 6.7 ± 3.4 4.4 ± 0.9 5.1 ± 1.7 7.9 ± 2.0 12.2 ± 3.4 <0.0001
Fat mass (%) 27.2 ± 8.4 25.2 ± 5.1 23.9 ± 7.4 28.9 ± 6.8 36.8 ± 8.1 <0.0001
Fat mass/Muscle mass 0.4 ± 0.2 0.4 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.6 ± 0.2 <0.0001
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-Value <0.05 indicates that the candidate variable is associated with the BMI categ
xpected event rates in subgroups of the model population. The
oodness of ﬁt of the logistic models was considered as good when
hepvaluewas>0.05. All these statisticswereperformedwithSAS®
oftware (version 9.3 – SAS System, SAS Institute Inc., Cary, NC,
SA). The level of signiﬁcance was set at p=0.05.
esults
The socio-demographic characteristics and medical data retro-
pectively collected from the 616 consecutive adults comprising
he sample study are presented according to BMI categories in
able 1. Two thirds of the sample study group were female (61.4%).
heaverageagewas56.0±10.0years and74.6%of the sample study
roup were aged over 50 years. Two thirds of the analytic sam-
le study group were diagnosed as being metabolically unhealthy
n=372) while 20.0% had already at least one cardiovascular com-
lication (n=124).
According to BMI categories, 45.8% of the analytic sam-
le study group were considered to be of normal weight
18≤BMI<25kg/m2), while 19.2% and 16.5% were classiﬁed as
verweight (25≤BMI≤29kg/m2) and obese (BMI≥30kg/m2),
espectively. When the individuals were classiﬁed as underweight
18.5% – BMI<18kg/m2), the vast majority was aged between 40
able 3
pearman’s r correlation coefﬁcient computed to describe the relationship between BMI v
hole sample (N=616) and according to the four BMI categories.
Body composition Total BMI <18
N=616 n=114
Bone mass (kg) 0.39 0.56
p-Value <0.0001 <0.0001
Bone mass index (kg/m2) 0.49 0.54
p-Value <0.0001 <0.0001
Muscle mass (kg) 0.64 0.41
p-Value <0.0001 0.0017
Muscle mass index (kg/m2) 0.82 0.28
p-Value <0.0001 0.03
Muscle mass (%) −0.49 −0.12
p-Value <0.0001 NS
Fat mass (kg) 0.86 0.25
p-Value <0.0001 NS
Fat mass index (kg/m2) 0.83 0.22
p-Value <0.0001 NS
Fat mass (%) 0.52 0.089
p-Value <0.0001 NS
Fat mass/muscle mass 0.53 0.074
p-Value <0.0001 NS
-Value <0.05 indicates that the candidate variable is associated with the body mass ind
hen it is >0.05 then “NS” is mentioned.when it is >0.05 then “NS” is mentioned.
and 69 years (89.4%) and 93.7% were women. Patients with higher
BMI were signiﬁcantly older. Interestingly, when the metabolic
status was then considered, 78.0% and 86.3% of overweight and
obese individualsweremetabolically unhealthy respectively, 46.8%
and 52.6% of subjects classiﬁed into normal and underweight BMI
category were also considered as being biologically unhealthy.
Similarly, cardiovascular complicationsmainly concerned theover-
weight and obese sub-samples (78.2%).
Anthropometric data across BMI categories are detailed in
Tables 2 and3.While the averageheightwas similar across BMI cat-
egories, obviously, all anthropometric parameters increased with
the BMI values and categories. One interesting ﬁnding was that
while all estimates of the fat compartments were positively cor-
related with BMI categories, the percentage of MM was negatively
correlated with BMI values (r=−0.49; p<0.0001) and this across
all BMI categories. Mean MM and MMI values were higher within
the highest BMI categories (p<0.0001) and in metabolic and car-
diovascular healthy subgroups respectively in underweight and in
normal weight groups according to the BMI value (p=0.001). In
particular, when the body composition of normal and underweight
individuals according toBMI classiﬁcationwasanalyzed, the results
demonstrated that the unhealthy sub-sample had a lower MM and
a relative excess of FM compared to the healthy one. These ﬁndings
alues and the different body composition parameters. Results are presented for the
18≤BMI<24.9 25≤BMI<29.9 BMI≥30
n=282 n=118 n=102
0.39 −0.52 −0.59
<0.0001 NS NS
0.39 −0.11 0.21
<0.0001 NS NS
0.52 0.28 0.092
<0.0001 NS NS
0.64 0.23 0.47
<0.0001 NS 0.0005
−0.19 −0.31 −0.34
NS 0.02 0.01
0.37 0.55 0.73
<0.0001 <0.0001 <0.0001
0.30 0.53 0.71
0.0002 <0.0001 <0.0001
0.044 0.33 0.35
NS <0.001 0.011
0.06 0.32 0.29
NS 0.01 0.03
ex (BMI) values within the whole sample or within the BMI category considered,
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Table 4
Results of the multifactorial logistic model analysis performed to evaluate the predictive ability of the different anthropometric parameters considered for the metabolic and
cardiovascular health respectively. Results are given in the form of odds ratio (OR) systematically adjusted for gender and age, and smoking for any cardiovascular diseases,
and its 95% conﬁdence interval (CI; N=616).
Being metabolically unhealthy p-Value Any cardiovascular diseasesa p-Value
OR 95% CI OR 95% CI
Weight (kg) 1.05 1.03–1.06 <0.0001 1.05 1.03–1.06 <0.0001
Height (m) 1.02 1.00–1.05 NS 1.00 0.98–1.04 NS
BMI (kg/m2) 1.17 1.11–1.24 <0.0001 1.20 1.14–1.28 <0.001
BMI subgroups (kg/m2)
18≤BMI<24.9 1.00 – 1.00 –
BMI<18 1.28 0.69–2.37 NS 1.22 0.26–1.97 NS
25≤BMI<29.9 6.84 3.03–10.46 <0.0001 5.10 3.79–8.76 <0.0001
BMI≥30 8.05 4.23–10.07 <0.0001 5.74 3.41–8.98 <0.0001
Fat mass (kg) 1.00 0.97–1.03 NS 1.00 0.97–1.03 NS
Fat mass index (kg/m2) 1.30 1.19–1.47 <0.0001 1.22 1.13–1.32 <0.0001
% of fat mass 1.08 1.04–1.11 <0.0001 1.05 1.02–1.9 0.002
Muscle mass (kg) 1.00 0.98–1.02 NS 1.00 0.98–1.02 NS
Muscle mass index (kg/m2) 0.84 0.78–0.91 <0.0001 0.72 0.65–0.80 <0.0001
% of muscle mass 0.90 0.91–0.93 0.0001 0.95 0.92–0.98 0.008
Fat mass/muscle mass 15.45 11.77–20.17 <0.0001 16.61 10.49–21.33 <0.0001
OR, odds ratio, when OR>1.00 then the variable of interest is a factor related to the result variable; 95% CI =95% conﬁdence interval, when the value one is not within the
95% CI then the link is signiﬁcant; BMI, body mass index (kg/m2).
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t-Value <0.05 indicates that the candidate variable is associated with the result var
a Any cardiovascular diseases = suffering at least from high blood pressure, and/or
ajor arteries of the body (with or without symptoms or complications), and/or an
ere observed whatever the health outcomes (metabolic and car-
iovascular) and the muscle and fat readouts considered (p<0.01).
Results ofmultifactorial logisticmodels, systematically adjusted
or individuals’ age and gender, and smoking for any cardiovascu-
ar complications are presented in Table 4. Only overweight and
bese BMI categories were signiﬁcantly associated with metabolic
nd cardiovascular complications with, respectively, OR 6.84 (95%
I: 3.03–10.46) and 8.05 (95% CI: 4.23–12.07) and 5.10 (95% CI:
.79–8.76) and 5.74 (95% CI: 3.41–8.98). In all models, every body
eight component was signiﬁcantly predictive of metabolic and
ardiovascular health independently or combined except total FM
nd MM; FM and MM readouts were however inversely associated
ith the two outcomes. FM and MM indexes, which are equivalent
oncepts to BMI, were also signiﬁcantly but inversely associated
ith metabolic disease (respectively, OR=1.30, 95% CI: 1.19–1.47;
nd 0.84, 95% CI: 0.78–0.91) and cardiovascular complications
OR=1.22, 95% CI: 1.13–1.32; and 0.72, 95% CI: 0.65–0.80). Thus,
hile increasing values of percentage of FM and FMI adversely
mpacted metabolic and cardiovascular health, inversely increas-
ng values forMMI andpercentage ofMMpositively interferedwith
hese health-related risks. The FM/MM, taking into account the two
omponents togetherwasalso signiﬁcantly associatedwith the two
utcomes of interest (respectively, OR=15.45, 95%CI: 11.77–20.17;
nd 16.61, 95% CI: 10.49–21.33).
iscussion
The main ﬁnding of this study is that all readouts of the two
ajor components of the total body weight predicted signiﬁcantly
he metabolic and cardiovascular health. Thus, the total and per-
entage of FM and MM, the FM and MM indexes were independent
redictive markers of the body composition changes related to
ealth. Moreover, the FM/MM, taking into account simultaneously
hese two components was also signiﬁcantly identiﬁed. The BMI
alue was signiﬁcantly associated with such health risks, but the
igniﬁcant association was only observed with highest categories
i.e. overweight and obese). These ﬁndings are of particular interest
hen we consider that among individuals classiﬁed within normal
nd even underweight population according to BMI categorization,
he prevalence of metabolic and cardiovascular complications arewhen >0.05 then “NS” is mentioned.
aropathy (symptomatic or not), and/or atherosclerosis of supra aortic trunk and/or
iopathy of the lower limbs.
far from negligible in our analytic sample study group (see Table 1)
and as also depicted by others [1,11,12].
The major shortcoming of the BMI is that the actual composi-
tion of body weight is not taken into account. Indeed, excess of
body weight may be made up of adipose tissue or conversely mus-
cle hypertrophy both of which situations will be judged as “excess
mass.” Conversely a deﬁcit of BMI may be due to a MM deﬁcit or
a mobilization of adipose tissue or both combined. Consequently,
considering that BMI is the sum of FM and MM, an increase (or a
decrease) in BMI may be accounted for by a rise (or a drop) in one
component or in theother, or inboth components. The advantageof
the combined use of these indices is that one can judgewhether the
deﬁcit or excess of body weight is selectively due to a change in FM
vs. MMor both combined [13]. This is furthermore of interest when
we consider that these two components may have a completely
opposite and independent impact on metabolic risks and subse-
quently cardiovascular complications [1,14–19]. The association of
overweight–overfat and the development of major complications
is strongly linked to adiposity and its associated chronic inﬂamma-
tion and insulin resistance (IR) [1,15,20]. The utility of measuring
fat mass index vs. BMI in the screening of metabolic syndrome,
has been recently demonstrated by Liu et al. [3] in 1698 subjects
(aged 20–79 years) who participated in annual health check-ups
in Beijing, China. However, while the increase in body fat is the
most common explanation for the occurrence of IR [15]; over the
past few years it has become evident that changes in the metabolic
function of muscles played also a direct role [14,16–18]. Regard-
less of the speciﬁc intracellular mechanisms at the molecular level
[21–23], it is clear that IR and ultimately diabetes are not simply
the result of increased FM but rather related to alterations in the
metabolic function of muscle and reduced MM [14,19,23].
Partitioning BMI into MM and FM is however not possible
without associated measurement of body composition. Using this
two-compartment model merits however a reappraisal. It appears
to be of high interest to better identify how adultweightmay inter-
fere with health by more precisely exploring the wide range from
underweight/underlean to overweight/overfat individuals [13]. It
may also improve overweight and obesity management. Thus,
while for many physicians and people goals of overweight/obesity
therapy are to reduce body weight and maintain a lower body
weight for the long-term, our ﬁndings underline the imperative
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eed to increase, or at least to maintain, regular physical activity
ractice in addition to long-term nutritional adjustments. Exercise
mproves muscle function and, in some circumstances, increases
uscle mass as well. Improved function is not limited to the con-
ractile properties but also muscle metabolism [19] and hence
nhances insulin sensitivity [24]. However exercise seems to be
oreeffectiveatpreventing lossofmuscle and improving function-
lity [19,25] than of restoring lost muscle mass. Finally, exploring
ody composition through this two-compartmentmodel should be
ot only part of the initial assessment of overweight andobese indi-
iduals but should be part of a periodic follow-up. Thus the impact
f weight-loss programs on both FM and MM can be estimated and
ubsequently the level of caloric restriction and physical activity
eriodically re-adjusted accordingly.
Our study had some limitations. First, the study design lim-
ts our ability to draw causal inferences from the relationships
bserved. Thus, our study investigated neither adipokines to dif-
erentiate metabolically healthy from unhealthy individuals nor
he mode of transition to observe the impact of adiposity-related
hronic inﬂammation on metabolic and health outcomes. Indeed,
hether theoretically metabolically healthy overweight (MHO)
nd metabolically unhealthy overweight (MUHO) represent dis-
inct subtypes that could be predetermined genetically to confer
iffering metabolic and cardiovascular risks [26], these two enti-
ies may also represent transition phases in the natural course
f obesity, with MHO individuals ultimately turning into MUHO
15,27]. Thus investigating the chronic state of low-grade inﬂam-
ation usually described as associated with fat deposition should
e investigated. These measurements would have probably helped
o better extend risk prediction beyond BMI scores [2] by identi-
ying MUHO who do not yet exert overweight–obesity metabolic
attern and/or cardiovascular complications [15]. However, while
his would help to better deﬁne metabolic risk across the differ-
nt BMI categories this would have led to increase the number of
ndividuals at risk and subsequently the strength of the observed
ssociations.
Second, DEXA scan was used to estimate both fat and muscle
ass and like other estimation techniques, DEXA has sources of
rror. There can be inconsistent results between different scans
rom different manufacturers, and even different results between
achines from the same manufacturer. All DEXA-based body com-
osition measurements considered in our study were made on the
ame machine (model Discovery W, Hologic) that is the only one to
ncorporate the National Health and Nutrition Examination Survey
NHANES) whole body composition reference data [28]. While it is
sually believed that software upgrades may change the algorithm
sed to calculate body composition, the different upgrades per-
ormed during the study period have always been made to update
he same mode of functioning. Moreover multiple controls have
ertiﬁed the reproducibility of the measurements. Another source
f errorwith theuse ofDEXA scan is that it relies on the relationship
etween body composition and body water content. Indeed, this
ay be disturbed in pathological states that increase whole body
ater, suchas acute cardiacor renal failure.While this point ismore
articularly a concern when trying to measure change over time,
ndividuals with heart failure were not considered in our analytic
ample study group and in individuals with chronic renal disease,
n whom muscle mass would be overestimated [16].
Third, our analytic sample study group is not representative of
homogenous population. It is more representative of the interna-
ional community visiting Switzerland formedical care thanpeople
f strictly Swiss nationality. This is due to the heterogeneity of
he population consulting our clinic (i.e. one third of the sample
ere of non-Swiss origin) and that one composing the districts of
he towns of Lausanne and Geneva (Switzerland) [13]. It has been
emonstrated that there is a discrepancy between average BMI anddiology 65 (2015) 42–49
average relative body fat in certain ethnic groups [29]. For exam-
ple, a higher percentage body fat for the same BMI was observed
in a Chinese population compared to Caucasians. This indicates
that fat-mass index will be higher at the same BMI compared to
other populations. This ﬁnding alsomeans that population-speciﬁc
BMIs need to be developed when body composition is unknown,
whereas population-speciﬁc FM or MM indexes may be less warr-
anted [30,31].
Conclusion
Despite limitations, our ﬁndings suggest that considering the
two components of the bodyweight (i.e. FMandMM)are important
and complementarymeasurements in the evaluation of an individ-
ual’s nutritional status. These results may extend the exploration
of its impact on metabolic and cardiovascular health to normal and
underweight BMI categories and not only restrain it to overweight
and obese populations. Finally, these ﬁndings also underline the
interest of measuring body composition components in medical
check-ups to predict metabolic and cardiovascular diseases.
The interest of considering FM and MM index as well as
FM/MM to predict metabolic-associated health outcomes still
needs, however, to be further explored on the basis of longitudi-
nal studies. Similarly how changes in body composition over time
affect metabolic patterns, cardiovascular complications, and sur-
vival should also be investigated. Moreover, cut-off values have
still to be determined as a function of age and gender and probably
ethnic origin as well. Finally, due to DEXA-associated costs and its
limitedaccessibility, theaccuracyand reliabilityof alternative tech-
niques in measuring body composition components should also be
further explored.
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